von Willebrand factor antigen: a novel on-treatment predictor of response to antiviral therapy in chronic hepatitis C genotypes 1 and 4.

Pramhas, Sibylle

von Willebrand factor antigen: a novel on-treatment predictor of response to antiviral therapy in chronic hepatitis C genotypes 1 and 4. [electronic resource] - Antiviral therapy 2010 - 831-9 p. digital

Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't

2040-2058

10.3851/IMP1654 doi


Administration, Oral
Adult
Antiviral Agents--therapeutic use
Drug Therapy, Combination
Female
Genotype
Hepatitis C, Chronic--drug therapy
Humans
Male
Middle Aged
Predictive Value of Tests
Prospective Studies
Recurrence
Ribavirin--administration & dosage
von Willebrand Factor--immunology